Assertio Therapeutics Financial Overview
Assertio Therapeutics's market cap is currently $63.78M. The company's EPS TTM is $1.65; its P/E ratio is -2.11; Assertio Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-3.11. See an overview of income statement, balance sheet, and cash flow financials.
